GlassScriptPhysician profile
Kiera E Farry
NPI 1114344108
$5,197.99
in general payments reported to CMS, 2019-2025
33 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $99.19 · 2021: $496 · 2022: $930 · 2023: $1,564 · 2024: $1,136 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,219.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $649.32 | 2020-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $648.14 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $491.42 | 2019-2025 | Watchman Flx, Watchman, Varithena Administration Pack |
| Atricure, INC. | $440.10 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $391.91 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.74 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $219.82 | 2021-2023 | Verquvo |
| Esperion Therapeutics, INC. | $216.13 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $184.17 | 2021-2025 | Wainua, Farxiga |
| Janssen Pharmaceuticals, INC | $181.06 | 2021-2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $167.37 | 2019-2024 | |
| Novo Nordisk INC | $146.75 | 2024 | |
| Abiomed | $137.56 | 2022-2025 | |
| Edwards Lifesciences Corporation | $134.50 | 2023-2024 | Konect Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Philips North America LLC | $126.26 | 2022-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $101.69 | 2022-2023 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $85.50 | 2023 | Evkeeza |
| Medtronic, INC. | $76.15 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.93 | 2021-2023 | Jardiance |
| Pfizer INC. | $57.06 | 2022-2024 | |
| Lexicon Pharmaceuticals, INC. | $52.28 | 2023 | Inpefa |
| Altathera Pharmaceuticals LLC | $44.90 | 2022-2023 | Sotalol Hydrochloride |
| Daiichi Sankyo INC. | $33.98 | 2023 | Injectafer |
| Heartflow, INC. | $31.25 | 2024 | |
| Medicomp INC | $30.15 | 2024 | Telepatch Cardiac Monitor |
| Kiniksa Pharmaceuticals International, Plc | $29.34 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $28.05 | 2023 | Arcalyst |
| Amarin Pharma, INC. | $27.75 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $24.95 | 2021-2022 | |
| Inspire Medical Systems, INC. | $24.25 | 2023 | Inspire |
| Bard Peripheral Vascular, INC. | $21.52 | 2023 | Venclose Maven Catheter |
| Cleerly, INC. | $20.16 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Sanofi-Aventis U.S. LLC | $12.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiera Farry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.